Stock Scorer

Genmab A/S (GMAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 350M 700M 1.1B Q2 '24: 779M Q2 '25: 925M Q2 '24 Q2 '25

Gross Profit Quarterly

0 300M 600M 900M Q2 '24: 751M Q2 '25: 868M Q2 '24 Q2 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

0 150M 300M 450M Q2 '24: 236M Q2 '25: 360M Q2 '24 Q2 '25

Net Income Quarterly

0 150M 300M 450M Q2 '24: 203M Q2 '25: 336M Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 20M 40M 60M Q2 '24: 28M Q2 '25: 57M Q2 '24 Q2 '25

EPS Annual

0.00 6.00 12.00 18.00 FY23: 9.58 FY24: 17.53 FY25: 15.37 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for GMAB: Operating Cash Flow, Free Cash Flow, Shares Outstanding. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.